CN115074356A - New coronavirus nucleic acid extraction promoter and application thereof - Google Patents
New coronavirus nucleic acid extraction promoter and application thereof Download PDFInfo
- Publication number
- CN115074356A CN115074356A CN202210989492.6A CN202210989492A CN115074356A CN 115074356 A CN115074356 A CN 115074356A CN 202210989492 A CN202210989492 A CN 202210989492A CN 115074356 A CN115074356 A CN 115074356A
- Authority
- CN
- China
- Prior art keywords
- nucleic acid
- accelerator
- extraction
- detection
- samples
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000605 extraction Methods 0.000 title claims abstract description 53
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 52
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 52
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 52
- 241000711573 Coronaviridae Species 0.000 title claims abstract description 23
- 239000003638 chemical reducing agent Substances 0.000 claims abstract description 8
- 239000003599 detergent Substances 0.000 claims abstract description 7
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical group [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 9
- 239000003623 enhancer Substances 0.000 claims description 4
- 239000008363 phosphate buffer Substances 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 2
- 239000000243 solution Substances 0.000 claims description 2
- 238000001514 detection method Methods 0.000 abstract description 19
- 238000000034 method Methods 0.000 abstract description 11
- 239000011324 bead Substances 0.000 abstract description 6
- 230000035945 sensitivity Effects 0.000 abstract description 4
- 241000700605 Viruses Species 0.000 abstract description 3
- 239000008055 phosphate buffer solution Substances 0.000 abstract description 3
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 238000005070 sampling Methods 0.000 description 9
- 239000003761 preservation solution Substances 0.000 description 7
- 230000003612 virological effect Effects 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 6
- 238000010790 dilution Methods 0.000 description 6
- 239000012895 dilution Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 238000004321 preservation Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 102000006382 Ribonucleases Human genes 0.000 description 4
- 108010083644 Ribonucleases Proteins 0.000 description 4
- 241001112090 Pseudovirus Species 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 210000003800 pharynx Anatomy 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 2
- 239000003398 denaturant Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 150000002357 guanidines Chemical class 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241001678559 COVID-19 virus Species 0.000 description 1
- 108700002099 Coronavirus Nucleocapsid Proteins Proteins 0.000 description 1
- 102000016911 Deoxyribonucleases Human genes 0.000 description 1
- 108010053770 Deoxyribonucleases Proteins 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 108090000621 Ribonuclease P Proteins 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 238000007886 magnetic bead extraction Methods 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000003161 ribonuclease inhibitor Substances 0.000 description 1
- -1 salt ion Chemical class 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
- C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
- C12N15/1013—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers by using magnetic beads
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
本发明公开一种新冠病毒核酸提取促进剂及其应用,属于生物检测的技术领域。为了解决样品放置时间超过24h再进行提取,内参的检测Ct值会下降,有的样品内参甚至检测不到Ct值的问题。本发明提供一种新冠病毒核酸提取促进剂,所述促进剂的成分如下:还原剂、去污剂和磷酸盐缓冲溶液。在新冠采集的样品中加入该试剂的实验结果显示,它可以使通过磁珠法提取的样品中内参和新冠病毒核酸含量提高10倍以上。该核酸提取促进剂应用于新冠检测可以明显提高病毒的检测灵敏度,提高新冠弱阳性样品的检出率。
The invention discloses a novel coronavirus nucleic acid extraction accelerator and an application thereof, belonging to the technical field of biological detection. In order to solve the problem that the detection Ct value of the internal reference will decrease, and some samples cannot even detect the Ct value of the internal reference, in order to solve the problem that the sample is placed for more than 24 hours before extraction. The present invention provides a novel coronavirus nucleic acid extraction accelerator. The components of the accelerator are as follows: a reducing agent, a detergent and a phosphate buffer solution. The experimental results of adding this reagent to the samples collected by the new crown showed that it can increase the content of the internal reference and the new coronavirus nucleic acid in the samples extracted by the magnetic bead method by more than 10 times. The application of the nucleic acid extraction accelerator in the detection of new crowns can significantly improve the detection sensitivity of the virus and improve the detection rate of weakly positive samples of the new crowns.
Description
技术领域technical field
本发明属于生物检测的技术领域,具体涉及一种新冠病毒核酸提取促进剂及其应用。The invention belongs to the technical field of biological detection, and in particular relates to a novel coronavirus nucleic acid extraction accelerator and application thereof.
背景技术Background technique
在现代分子生物学实验中,提取各种来源的DNA和RNA是许多实验的必备过程。DNA酶和RNA酶是专门降解核酸的酶,这些酶在自然界中广泛存在,因此,暴露在外界的核酸分子很容易降解,尤其是在组织细胞中,这两种酶的含量非常高,如果处理不当,很难在这些原料中提取到完整的核酸分子。在完整的病毒颗粒中,病毒核酸与各种蛋白结合,降解DNA和RNA的酶无法接触到核酸,因此,病毒的核酸可以完整保存。如果病毒核酸从病毒颗粒中释放后,没有保护措施它们很快降解,因此,这种情况下获得的病毒核酸很难保证各种分子实验的成功,尤其是病毒的检测实验。In modern molecular biology experiments, the extraction of DNA and RNA from various sources is an essential process for many experiments. DNase and RNase are enzymes that specifically degrade nucleic acids. These enzymes are widely found in nature. Therefore, nucleic acid molecules exposed to the outside world are easily degraded, especially in tissue cells. The content of these two enzymes is very high. Improperly, it is difficult to extract complete nucleic acid molecules from these raw materials. In a complete viral particle, the viral nucleic acid is bound to various proteins, and the enzymes that degrade DNA and RNA cannot access the nucleic acid. Therefore, the viral nucleic acid can be preserved intact. If viral nucleic acids are released from virus particles, they will be degraded quickly without protective measures. Therefore, the viral nucleic acids obtained in this case are difficult to guarantee the success of various molecular experiments, especially virus detection experiments.
在新冠检测中,样品均来源于咽或鼻腔,这些样品不仅含有大量的粘液,而且在取样过程中拭子也将上皮细胞大量刮下。当这些细胞破裂时会释放大量的RNA酶,如果不将这些酶进行彻底的失活,新冠病毒的核酸释放出来后会很快水解,在这种情况下即使是阳性样品也很难在荧光RT-PCR中检测出阳性结果。因此,目前在新冠检测管中的裂解液均加入了一定量的胍盐作为变性剂,这些变性剂在一定时间内可以有效抑制RNA酶的活性。但是,我们经常在检测新冠核酸过程中发现,如果样品放置时间超过24h,内参的检测Ct值会下降,有的样品内参甚至检测不到Ct值。这些现象表明只用胍盐作为RNA酶的抑制剂并不理想,样品在裂解液中裂解后还存在少量有生物活性的RNA酶。In the new crown test, the samples were all derived from the pharynx or nasal cavity. These samples not only contained a large amount of mucus, but also scraped off a large number of epithelial cells during the sampling process. When these cells rupture, a large amount of RNases are released. If these enzymes are not completely inactivated, the nucleic acid of the new coronavirus will be hydrolyzed quickly after being released. - Positive result detected in PCR. Therefore, at present, a certain amount of guanidine salt is added to the lysate in the new crown detection tube as a denaturant, and these denaturants can effectively inhibit the activity of RNase within a certain period of time. However, we often find in the process of detecting new crown nucleic acid that if the sample is placed for more than 24 hours, the detection Ct value of the internal reference will decrease, and some samples cannot even detect the Ct value of the internal reference. These phenomena indicate that only using guanidine salts as RNase inhibitors is not ideal, and there is still a small amount of biologically active RNases after the samples are lysed in the lysis buffer.
发明内容SUMMARY OF THE INVENTION
本发明的目的是为了解决样品放置时间超过24h再进行提取,内参的检测Ct值会下降,有的样品内参甚至检测不到Ct值的问题。The purpose of the present invention is to solve the problem that the detected Ct value of the internal reference will decrease and the internal reference of some samples cannot even detect the Ct value before extraction is performed after the sample is placed for more than 24 hours.
本发明提供一种新冠病毒核酸提取的促进剂,所述促进剂的成分如下:还原剂、去污剂和磷酸盐缓冲溶液。The present invention provides an accelerator for nucleic acid extraction of novel coronavirus. The composition of the accelerator is as follows: a reducing agent, a detergent and a phosphate buffer solution.
进一步地限定,所述还原剂为DTT。Further defined, the reducing agent is DTT.
进一步地限定,所述去污剂为SDS。Further defined, the detergent is SDS.
进一步地限定,所述磷酸盐缓冲液为磷酸氢二钠。Further limited, the phosphate buffer is disodium hydrogen phosphate.
进一步地限定,所述促进剂的成分如下:DTT、SDS和磷酸氢二钠。To be further defined, the components of the accelerator are as follows: DTT, SDS and disodium hydrogen phosphate.
进一步地限定,所述促进剂的成分如下:0.1-10mM的DTT、0.5-5%的SDS和0.1-1M的磷酸氢二钠,pH 为7.2。To be further defined, the composition of the accelerator is as follows: 0.1-10 mM DTT, 0.5-5% SDS and 0.1-1 M disodium hydrogen phosphate, pH 7.2.
进一步地限定,所述促进剂的成分如下:10mM的DTT、5%的SDS和1M的磷酸氢二钠,pH 为7.2。Further defined, the composition of the accelerator is as follows: 10 mM DTT, 5% SDS and 1 M disodium hydrogen phosphate, pH 7.2.
进一步地限定,所述促进剂的成分如下:0.1mM的DTT、0.5%的SDS和0.1M的磷酸氢二钠,pH 为7.2。To be further defined, the composition of the accelerator is as follows: 0.1 mM DTT, 0.5% SDS and 0.1 M disodium hydrogen phosphate, pH 7.2.
本发明提供上述的促进剂在制备提取新冠病毒RNA试剂盒中的应用。The present invention provides the application of the above-mentioned accelerator in the preparation of a kit for extracting novel coronavirus RNA.
本发明提供上述的促进剂在提高新冠病毒核酸提取效率中的应用。The present invention provides the application of the above-mentioned accelerator in improving the extraction efficiency of novel coronavirus nucleic acid.
有益效果:新冠病毒核酸提取促进剂的配方,主要包含有还原剂、去污剂和磷酸盐缓冲溶液,其中还原剂包括DTT,去污剂包括SDS。还原剂的使用终浓度在0.1-10mM之间,最佳的使用浓度为1mM,其在保护剂中的功能是破坏RNA酶中的二硫键,使RNA酶永久性失活;去污剂的使用终浓度为0.5-5%之间,推荐的使用终浓度为0.5%,其功能是去除RNA中的蛋白质成分,尤其在磁珠提取过程中可以有效分离核酸和蛋白之间的联系,促进核酸与磁珠的结合;磷酸盐的终浓度为0.1-1M,推荐的使用终浓度为0.1M,其在提取促进剂中的功能是给核酸提供一个稳定的缓冲环境,有利于核酸的稳定保存,并且在核酸提取中提供一个盐离子环境,使磁珠提取RNA或DNA中携带较强的正离子,促进核酸和磁珠的静电结合。Beneficial effect: The formula of the novel coronavirus nucleic acid extraction accelerator mainly contains a reducing agent, a detergent and a phosphate buffer solution, wherein the reducing agent includes DTT, and the detergent includes SDS. The final concentration of reducing agent is between 0.1-10mM, and the best concentration is 1mM. Its function in protective agent is to destroy the disulfide bond in RNase and permanently inactivate RNase; The final concentration is between 0.5-5%, and the recommended final concentration is 0.5%. Its function is to remove the protein component in RNA, especially in the process of magnetic bead extraction, it can effectively separate the connection between nucleic acid and protein, and promote nucleic acid. Binding with magnetic beads; the final concentration of phosphate is 0.1-1M, and the recommended final concentration is 0.1M. Its function in the extraction accelerator is to provide a stable buffer environment for nucleic acids, which is conducive to the stable preservation of nucleic acids. In addition, a salt ion environment is provided in nucleic acid extraction, so that the magnetic beads extract RNA or DNA to carry strong positive ions, and promote the electrostatic binding of nucleic acid and magnetic beads.
附图说明Description of drawings
图1为检测结果为阳性的最大稀释倍数;Fig. 1 is the maximum dilution factor that the detection result is positive;
图2为检测结果为阳性的最大稀释倍数。Figure 2 shows the maximum dilution for a positive test result.
具体实施方式Detailed ways
实施例1.新冠病毒核酸提取促进剂Example 1. Novel coronavirus nucleic acid extraction accelerator
新冠病毒核酸提取促进剂的配方(10x)进行实验操作如下:The formula (10x) of the new coronavirus nucleic acid extraction accelerator is experimentally operated as follows:
提取促进剂配方:DTT 10mMExtraction accelerator formula: DTT 10mM
SDS 5% SDS 5%
磷酸氢二钠: 1M Disodium hydrogen phosphate: 1M
pH 7.2。 pH 7.2.
对比例1.新冠病毒核酸提取促进剂Comparative example 1. Novel coronavirus nucleic acid extraction accelerator
提取促进剂对照配方1:SDS 5%Extraction accelerator control formula 1: SDS 5%
磷酸氢二钠: 1M Disodium hydrogen phosphate: 1M
pH 7.2。 pH 7.2.
对比例2.新冠病毒核酸提取促进剂Comparative example 2. Novel coronavirus nucleic acid extraction accelerator
提取促进剂对照2配方:DTT 10mMExtraction Enhancer Control 2 Recipe: DTT 10mM
磷酸氢二钠: 1M Disodium hydrogen phosphate: 1M
pH 7.2。 pH 7.2.
对比例3.新冠病毒核酸提取促进剂Comparative example 3. Novel coronavirus nucleic acid extraction accelerator
提取促进剂对照配方3:DTT 10mMExtraction Enhancer Control Formulation 3: DTT 10mM
SDS 5% SDS 5%
pH 7.2。 pH 7.2.
利用以下实验验证实验效果:Use the following experiments to verify the experimental effect:
新冠病毒的RNA提取方法:New coronavirus RNA extraction method:
1.取5支空的样品采样管A1、A2、A3、A4和B1,每管加入1.8ml商品化的样品保存液,在A1至A4管中分别加入200µl体积的提取促进剂(实施例1)、提取促进剂(对比例1)、提取促进剂(对比例2)和提取促进剂(对比例3),在B1管中加入200µl的纯水作为对照。1. Take 5 empty sample sampling tubes A1, A2, A3, A4 and B1, add 1.8ml of commercial sample preservation solution to each tube, and add 200µl volume of extraction accelerator (Example 1) to tubes A1 to A4 respectively. ), extraction accelerator (comparative example 1), extraction accelerator (comparative example 2) and extraction accelerator (comparative example 3), add 200 µl of pure water to tube B1 as a control.
2.取一管放有6ml样品保存液的采样管C,用采样拭子采集两位健康人的咽部样品。将采集的咽拭子在保存液中充分搅拌,使采集到的样品充分从拭子释放到保存液中。2. Take a sampling tube C containing 6 ml of sample preservation solution, and use a sampling swab to collect pharyngeal samples of two healthy people. The collected throat swab is fully stirred in the preservation solution, so that the collected sample is fully released from the swab into the preservation solution.
3.将C管中的样品分别取1ml加入到A1-A4管和B1管中。由于从样品采集到样品送到检测实验室进行检测的时间通常需要1-4小时,为了模拟这个过程时间,将加入样品的采样管A1-A4和B1在室温下先放置24h,然后分别从A1-A4和B1中取200ul进行磁珠法(试剂盒购自硕世公司)提取样品中的核酸。3. Take 1ml of the sample in tube C and add it to tubes A1-A4 and tube B1 respectively. Since it usually takes 1-4 hours from sample collection to sample delivery to the testing laboratory for testing, in order to simulate this process time, the sampling tubes A1-A4 and B1 into which the samples were added were first placed at room temperature for 24 hours, and then separated from A1. - Take 200ul from A4 and B1 to extract nucleic acid in the sample by magnetic bead method (the kit was purchased from Shuo Shi Company).
4.样品在自动提取仪中提完后,从洗脱液中取5µl进行荧光RT-PCR检测,检测的试剂盒是购自武汉明德公司的新型冠状病毒2019-nCoV核酸检测试剂盒(荧光PCR法)。检测的效果通过样品中检测到的内参RNase-P基因的Ct值进行评价。4. After the sample is extracted in the automatic extractor, take 5µl from the eluate for fluorescence RT-PCR detection. PCR method). The detection effect was evaluated by the Ct value of the internal reference RNase-P gene detected in the sample.
结果显示加入提取促进剂的A1样品组Ct值与加入提取促进剂对照的A2、A3、A4和不加任何提取促进剂的对照组B1相比分别降低了大约4.80%、4.86%、2.67%和10.36%。这些结果如表1表明,在提取促进剂配方中各种成分对核酸检测均具有明显降低核酸Ct值的功能,证明提取的核酸含量明显提高。对提取的样品通过10倍系列稀释或2倍倍比稀释,进一步检测样品中核酸的含量变化情况,结果显示样品A1提取的核酸做1万倍稀释时还能检测为阳性,但是对照样品A2、A3、A4和B1提取的核酸只能在做了4000倍、4000倍、2000倍和1000倍时才能检测到阳性(如图1所示),它们再做进一步稀释检测则为阴性。这些结果表明,加入提取促进剂的样品提取到的核酸比不加任何提取促进剂的样品提高10倍以上,比加入各种提取促进剂对照组的样品A2、A3和A4分别提高2.5倍、2.5倍和5倍以上(如表2所示)。这些结果很明显表明,提取促进剂能有效提高样品中RNA检测的效率,而且各种成分均具有不同程度提高核酸提取效率的功能,它们合在一起对核酸的提取效果具有正向协同作用。The results showed that the Ct value of the A1 sample group added with the extraction accelerator was reduced by about 4.80%, 4.86%, 2.67% and 10.36%. These results are shown in Table 1, and various components in the extraction accelerator formulation have the function of significantly reducing the nucleic acid Ct value for nucleic acid detection, which proves that the extracted nucleic acid content is significantly increased. The extracted samples were further tested for changes in nucleic acid content by 10-fold serial dilution or 2-fold dilution. The results showed that the nucleic acid extracted from sample A1 could still be detected as positive when diluted 10,000 times, but the control samples A2, A2, The nucleic acids extracted from A3, A4 and B1 can only be detected positive when they are 4000 times, 4000 times, 2000 times and 1000 times (as shown in Figure 1), and they are negative when they are further diluted. These results show that the nucleic acid extracted from the samples with the addition of the extraction accelerator is more than 10 times higher than that of the samples without any extraction accelerator, and 2.5 times and 2.5 times higher than the samples A2, A3 and A4 of the control group added with various extraction accelerators, respectively. times and more than 5 times (as shown in Table 2). These results clearly show that the extraction enhancer can effectively improve the efficiency of RNA detection in the sample, and various components have the function of improving the nucleic acid extraction efficiency to different degrees, and they together have a positive synergistic effect on the nucleic acid extraction effect.
表1Table 1
注:敏感度是检测为阳性的样品最大稀释倍数的比值,有Ct值是阳性,无Ct值是阴性。Note: Sensitivity is the ratio of the maximum dilution ratio of the samples tested positive, with Ct value being positive and no Ct value being negative.
表2:A1组检测灵敏度相对其它对照组提高的倍数Table 2: The multiple improvement of the detection sensitivity of the A1 group compared with other control groups
下面的实验操作是将配制好的提取促进剂和各种提取促进剂对照应用于新冠病毒核酸的提取,新冠病毒颗粒以我们制备的假病毒代替。具体操作和实验结果如下:The following experimental operation is to apply the prepared extraction promoter and various extraction promoters to the extraction of new coronavirus nucleic acid, and the new coronavirus particles are replaced by the pseudovirus prepared by us. The specific operation and experimental results are as follows:
1.取5支空的样品采样管C1、C2、C3、C4和D1,每管加入1.8ml的商品化的样品保存液,然后在C1至C4采样管中分别加入200µl体积的提取促进剂、提取促进剂对照1、提取促进剂对照2和提取促进剂对照3,在D1管中加入200ul的纯水作为对照。1. Take 5 empty sample sampling tubes C1, C2, C3, C4 and D1, add 1.8ml of commercial sample preservation solution to each tube, and then add 200µl volume of extraction accelerator, Extraction accelerator control 1, extraction accelerator control 2 and extraction accelerator control 3, add 200ul of pure water to the D1 tube as a control.
2. 取一管放有6ml样品保存液的采样管E,用采样拭子采集两位健康人的咽部样品。将采集的咽拭子在保存液中充分搅拌,同时加入200ul的假病毒溶液,充分混合后将E管中的液体分别取1ml加入到C1、C2、C3、C4和D1管中。2. Take a sampling tube E containing 6 ml of sample preservation solution, and use a sampling swab to collect pharyngeal samples from two healthy people. The collected throat swabs were fully stirred in the preservation solution, and 200 ul of pseudovirus solution was added at the same time. After thorough mixing, 1 ml of the liquid in tube E was added to tubes C1, C2, C3, C4 and D1 respectively.
3.由于从样品采集到样品送到检测实验室检测的时间通常需要1-4小时,为了模拟这个过程时间,将加入样品的所有采样管先在室温放置24h,然后分别从各管中取200ul进行磁珠法(试剂盒购自硕世公司)提取样品中的核酸。3. Since it usually takes 1-4 hours from sample collection to sample delivery to the testing laboratory, in order to simulate this process time, put all the sampling tubes into which the samples are added at room temperature for 24 hours, and then take 200ul from each tube. The nucleic acid in the sample was extracted by magnetic bead method (the kit was purchased from Shuo Shi Company).
4. 样品在自动提取仪中提完后,从洗脱液中取5µl进行荧光RT-PCR检测,检测的试剂盒购自武汉明德公司。检测的效果通过样品中新冠病毒N基因和ORF1ab基因的Ct值进行评价。4. After the sample was extracted in the automatic extractor, 5µl was taken from the eluate for fluorescence RT-PCR detection. The detection kit was purchased from Wuhan Mingde Company. The effect of detection was evaluated by the Ct values of the new coronavirus N gene and ORF1ab gene in the sample.
结果显示(如下表3和4),在加入提取促进剂的样品C1中,N基因和ORF1ab基因的Ct值分别比提取促进剂对照组的C2、C3、C4和不加任何提取促进剂的对照组D1平均降低了14.93%、6.34%、5.59%和2.1%, ORF1ab基因的Ct值分别比提取促进剂对照C2、C3、C4和不加任何提取促进剂的对照D1组平均降低了13.34%、7.41%、6%和2.35%。The results show (Tables 3 and 4 below), in the sample C1 added with the extraction promoter, the Ct values of the N gene and ORF1ab gene were higher than those of the extraction promoter control group C2, C3, C4 and the control without any extraction promoter. Group D1 average reduced by 14.93%, 6.34%, 5.59%, and 2.1%. The CT values of the ORF1AB gene were reduced by 13.34%, respectively, and the control of the D1 group without any extraction promotion agent, respectively. 7.41%, 6% and 2.35%.
对提取的新冠假病毒核酸进行10倍或2倍倍比稀释,进一步分析提取到的病毒核酸的含量变化,结果显示样品C1、C2、C3、C4和D1提取的核酸N和ORF1ab基因检测为阳性的最大稀释倍数均分别为12000、4000、4000、2000和1000倍(如图2所示),加入提取促进剂的C1组比提取促进剂对照组C2、C3、C4和不加任何提取促进剂的D1组提取的样品核酸分别提高3倍、3倍、6倍和12倍(如表5所示)。这些结果表明,核酸提取促进剂能有效提高样品中新冠病毒核酸的检测效率。而且各种成分均具有不同程度提高新冠病毒核酸提取效率的功能,它们合在一起对病毒核酸的提取效果具有正向协同作用。The extracted nucleic acid of the new coronavirus pseudovirus was diluted 10-fold or 2-fold, and the content of the extracted viral nucleic acid was further analyzed. The results showed that the nucleic acids N and ORF1ab genes extracted from samples C1, C2, C3, C4 and D1 were positive. The maximum dilution ratios of the samples were 12,000, 4,000, 4,000, 2,000 and 1,000 times respectively (as shown in Figure 2). The C1 group with the addition of the extraction promoter was better than the extraction promoter control group C2, C3, C4 and without any extraction promoter. The sample nucleic acids extracted from the D1 group were increased by 3 times, 3 times, 6 times and 12 times respectively (as shown in Table 5). These results show that the nucleic acid extraction accelerator can effectively improve the detection efficiency of 2019-nCoV nucleic acid in samples. Moreover, various components have the function of improving the extraction efficiency of new coronavirus nucleic acid to varying degrees, and together they have a positive synergistic effect on the extraction effect of viral nucleic acid.
表3table 3
注:敏感度是检测为阳性的样品最大稀释倍数的比值,有Ct值是阳性,无Ct值是阴性。Note: Sensitivity is the ratio of the maximum dilution ratio of the samples tested positive, with Ct value being positive and no Ct value being negative.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210989492.6A CN115074356A (en) | 2022-08-18 | 2022-08-18 | New coronavirus nucleic acid extraction promoter and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210989492.6A CN115074356A (en) | 2022-08-18 | 2022-08-18 | New coronavirus nucleic acid extraction promoter and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115074356A true CN115074356A (en) | 2022-09-20 |
Family
ID=83244282
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210989492.6A Pending CN115074356A (en) | 2022-08-18 | 2022-08-18 | New coronavirus nucleic acid extraction promoter and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115074356A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014099121A1 (en) * | 2012-12-20 | 2014-06-26 | General Electric Company | Formulations for nucleic acid stabilization on solid substrates |
CN109991303A (en) * | 2019-02-27 | 2019-07-09 | 北京工商大学 | Rapid identification of single flower honey by capillary electrophoresis |
CN111808988A (en) * | 2020-06-09 | 2020-10-23 | 广州市金圻睿生物科技有限责任公司 | COVID-19 nucleic acid releasing agent and nucleic acid detection kit |
CN114634925A (en) * | 2020-12-15 | 2022-06-17 | 深圳市帝迈生物技术有限公司 | Nucleic acid extraction kit and method for extracting nucleic acid |
-
2022
- 2022-08-18 CN CN202210989492.6A patent/CN115074356A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014099121A1 (en) * | 2012-12-20 | 2014-06-26 | General Electric Company | Formulations for nucleic acid stabilization on solid substrates |
CN109991303A (en) * | 2019-02-27 | 2019-07-09 | 北京工商大学 | Rapid identification of single flower honey by capillary electrophoresis |
CN111808988A (en) * | 2020-06-09 | 2020-10-23 | 广州市金圻睿生物科技有限责任公司 | COVID-19 nucleic acid releasing agent and nucleic acid detection kit |
CN114634925A (en) * | 2020-12-15 | 2022-06-17 | 深圳市帝迈生物技术有限公司 | Nucleic acid extraction kit and method for extracting nucleic acid |
Non-Patent Citations (1)
Title |
---|
陈雄毅等: ""三种核酸提取方法在2019新型冠状病毒检测中的比较"", 《医学检验与临床》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111690640B (en) | Virus preservation solution of highly compatible magnetic bead method virus nucleic acid extraction kit | |
US12031125B2 (en) | Method for isolating extracellular nucleic acids using anion exchange particles | |
US20230183776A1 (en) | Method for reducing host nucleic acids in biological sample and applications | |
CN113151397B (en) | Nucleic acid extraction kit for extracting virus sample based on magnetic bead method | |
CN113388611B (en) | Kit for extracting stable bacterial genomic DNA by magnetic bead method and its extraction method | |
CN116590279A (en) | Kit for extracting plasma free DNA (deoxyribonucleic acid) based on hydroxyl magnetic beads and application method | |
CN115637267A (en) | A nucleic acid extraction reagent, its kit and extraction method | |
CN112899268B (en) | Kit for extracting viral nucleic acid by magnetic bead method | |
CN115074356A (en) | New coronavirus nucleic acid extraction promoter and application thereof | |
CN117230060B (en) | Pre-lysis solution, kit and method for extracting genome DNA | |
CN114807120A (en) | High-sensitivity virus nucleic acid extraction kit | |
CN109439656A (en) | A kind of bulk sample genome extraction kit | |
WO2025112952A1 (en) | Reagent combination, kit and method for extracting free dna in plasma | |
CN114479129A (en) | Reagent for rapidly extracting nucleic acid by using paramagnetic particle method and nucleic acid extraction method | |
CN116355893B (en) | Magnetic bead method nucleic acid extraction kit and application thereof | |
CN111269284B (en) | Reagent and method for simultaneous isolation of protein and RNA in cytoplasm and nucleus | |
CN115786327A (en) | Alcohol-free cleaning solution and application method thereof in extraction of new coronavirus nucleic acid | |
CN115247171A (en) | Splitting binding solution, kit and extraction method suitable for extracting pathogen nucleic acid from throat swab, saliva, serum and plasma | |
WO2024145938A1 (en) | Kit for extracting nucleic acid by means of magnetic bead method and use thereof | |
WO2024017155A1 (en) | Lysis composition | |
CN114015806B (en) | Coronavirus quality control product diluent and preparation method and application thereof | |
CN112725336B (en) | A lysis binding solution and kit for rapid RNA extraction using magnetic beads and their application | |
AU2021103963A4 (en) | Paper-based chromatographic viral nucleic acid extraction kit | |
CN117587004A (en) | Lysis conjugate solution, kit and extraction method for fungal DNA extraction and their applications | |
CN119506396A (en) | Alcohol-free lysis buffer and nucleic acid extraction kit suitable for nucleic acid extraction from various samples |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220920 |